Renaissance Technologies LLC 13D and 13G filings for Opiant Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 09:32 am Sale | 2021-12-31 | 13G | Opiant Pharmaceuticals, Inc. OPNT | Renaissance Technologies LLC | 183,815 3.890% | -53,000 (-22.38%) | Filing |
| 2021-02-10 4:09 pm Purchase | 2020-07-17 | 13G | Opiant Pharmaceuticals, Inc. OPNT | Renaissance Technologies LLC | 236,815 5.560% | 236,815 (New Position) | Filing |